Home » New FDA Drug Approval Pathway Aims to Promote, Ease Enrichment Trials
New FDA Drug Approval Pathway Aims to Promote, Ease Enrichment Trials
The FDA is considering a new drug approval pathway intended to boost development of treatments targeting small subgroups of patients with serious or life-threatening conditions. The pathway would establish a new, speedier process for studying a new drug or biological product in a smaller subpopulation of patients with more serious manifestations of a disease.
Drug Industry Daily
Drug Industry Daily
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May